Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
24-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Issue 24-3
Glaucoma Dialogue Contents
Comment #1457
advertisement
Glaucoma Dialogue
IGR 24-3
There is no Glaucoma Dialogue in this issue
A Glaucoma Dialogue is available for the following issues:
24-1: Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma
22-1: Impaired TRPV4-eNOS signaling in trabecular meshwork elevates intraocular pressure in glaucoma
21-2: Reprogramming to recover youthful epigenetic information and restore vision
20-4: Review of hygiene and disinfection Recommendations for outpatient glaucoma care: A COVID era update
18-3: Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice
18-2: Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial
18-1: Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication
17-4: Structural and Functional Progression in the Early Manifest Glaucoma Trial
17-3: Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension
16-3: Induced pluripotent stem cells restore function in a human cell loss model of open-angle glaucoma
16-1: Glucose-induced temporary visual recovery in primary open-angle glaucoma: a double-blind, randomized study
15-2: Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review
15-1: Longitudinal hemodynamic changes within the optic nerve head in experimental glaucoma
14-3: Subspecialization in glaucoma surgery
14-2: Reduction in Intraocular Pressure after Cataract Extraction: The Ocular Hypertension Treatment Study
14-1: Cost-effectiveness of Medications Compared With Laser Trabeculoplasty in Patients With Newly Diagnosed Open-Angle Glaucoma
13-4: Retinal Ganglion Cell Layer Thickness and Local Visual Field Sensitivity in Glaucoma
13-3: Aqueous humor dynamics during the day and night in volunteers with ocular hypertension
13-1: A Randomized Trial of Brimonidine Versus Timolol in Preserving Visual Function: Results From the Low-pressure Glaucoma Treatment Study
12-4: Treating patients presenting with advanced glaucoma - Should we reconsider current practice?
12-3: Transscleral diode laser cycloablation in patients with good vision
12-2: Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes
12-1: Optical coherence tomography quantitative analysis of iris volume changes after pharmacologic mydriasis
11-4: Three-year follow-up of the tube versus trabeculectomy study
11-3: Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma
11-2: Axonal regeneration induced by repetitive electrical stimulation of crushed optic nerve in adult rats
11-1: Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model
10-4: Disc hemorrhages and treatment in the early manifest glaucoma trial
10-3: The additional yield of a periodic screening programme for open-angle glaucoma: A population-based comparison of incident glaucoma cases detected in regular ophthalmic care with cases detected during screening
10-2: Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma
10-1: Cost-effectiveness of treating ocular hypertension
9-4: Predictors of long-term progression in the Early Manifest Glaucoma Trial
9-3: Targeting amyloid-β in glaucoma treatment
Issue
24-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-3 (2024)
24-1/2 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement